ArticleMedicine2026
National trends of metabolically healthy and unhealthy obesity before and during the COVID-19 pandemic, 2007 to 2021: A representative serial study in South Korea.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changes in Restrictive Spirometric Pattern and Pulmonary Function Before and After the COVID-19 Pandemic Among Korean Adults: A Nationwide Cross-Sectional Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term, nationally representative trends in metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUHO) in South Korea remain limited. Thus, we aimed to analyze the prevalence trends of MHO and MUHO and compare rates before and during the coronavirus disease 2019 (COVID-19) pandemic. We analyzed adults aged ≥ 19 years from the Korea National Health and Nutrition Examination Survey (2007-2021), a nationally representative repeated cross-sectional survey. Obese adults were classified as MHO or MUHO using National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) guidelines. To assess pandemic impact, data were divided into before (2007-2019) and during (2020-2021) the pandemic. National prevalence and temporal changes were estimated using weighted linear and logistic regression with 95% confidence intervals (CIs). A total of 87,625 adults were included (56.51% female). MUHO prevalence consistently exceeded MHO across all years. In 2021, MHO prevalence was 3.63% (95% CI = 2.97-4.28) versus 15.02% (13.05-16.99) for MUHO. Before the pandemic, MHO prevalence increased steadily (β = 0.035 [95% CI = 0.016-0.055]) and continued to rise during the pandemic (β = 0.055 [0.006-0.104]). MUHO prevalence, however, grew more sharply before the pandemic (β = 0.073 [0.036-0.111]) but plateaued during the pandemic (β = 0.061 [-0.031 to 0.153]). This nationwide cross-sectional study highlights distinct trajectories of MHO and MUHO before and during COVID-19. Given the higher and persistent prevalence of MUHO, personalized strategies tailored to metabolic health status are essential in managing obesity in Korea, with important implications for public health policy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.